Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Front Pharmacol ; 13: 1085665, 2022.
Article in English | MEDLINE | ID: mdl-36569316

ABSTRACT

Molecular generation (MG) via machine learning (ML) has speeded drug structural optimization, especially for targets with a large amount of reported bioactivity data. However, molecular generation for structural optimization is often powerless for new targets. DNA-encoded library (DEL) can generate systematic, target-specific activity data, including novel targets with few or unknown activity data. Therefore, this study aims to overcome the limitation of molecular generation in the structural optimization for the new target. Firstly, we generated molecules using the structure-affinity data (2.96 million samples) for 3C-like protease (3CLpro) from our own-built DEL platform to get rid of using public databases (e.g., CHEMBL and ZINC). Subsequently, to analyze the effect of transfer learning on the positive rate of the molecule generation model, molecular docking and affinity model based on DEL data were applied to explore the enhanced impact of transfer learning on molecule generation. In addition, the generated molecules are subjected to multiple filtering, including physicochemical properties, drug-like properties, and pharmacophore evaluation, molecular docking to determine the molecules for further study and verified by molecular dynamics simulation.

2.
Front Immunol ; 12: 644396, 2021.
Article in English | MEDLINE | ID: mdl-33953716

ABSTRACT

The development of effective vaccines and delivery systems in aquaculture is a long-term challenge for controlling emerging and reemerging infections. Cost-efficient and advanced nanoparticle vaccines are of tremendous applicability in prevention of infectious diseases of fish. In this study, dihydrolipoamide dehydrogenase (DLDH) antigens of Vibrio alginolyticus were loaded into mesoporous silica nanoparticles (MSN) to compose the vaccine delivery system. Hydroxypropyl methylcellulose phthalate (HP55) was coated to provide protection of immunogen. The morphology, loading capacity, acid-base triggered release were characterized and the toxicity of nanoparticle vaccine was determined in vitro. Further, the vaccine immune effects were evaluated in large yellow croaker via oral administration. In vitro studies confirmed that the antigen could be stable in enzymes-rich artificial gastric fluid and released under artificial intestinal fluid environment. In vitro cytotoxicity assessment demonstrated the vaccines within 120 µg/ml have good biocompatibility for large yellow croaker kidney cells. Our data confirmed that the nanoparticle vaccine in vivo could elicit innate and adaptive immune response, and provide good protection against Vibrio alginolyticus challenge. The MSN delivery system prepared may be a potential candidate carrier for fish vaccine via oral administration feeding. Further, we provide theoretical basis for developing convenient, high-performance, and cost-efficient vaccine against infectious diseases in aquaculture.


Subject(s)
Bacterial Proteins , Bacterial Vaccines , Dihydrolipoamide Dehydrogenase , Fish Diseases , Nanoparticles , Perciformes , Silicon Dioxide , Vibrio Infections , Vibrio alginolyticus , Administration, Oral , Animals , Bacterial Proteins/chemistry , Bacterial Proteins/pharmacology , Bacterial Vaccines/chemistry , Bacterial Vaccines/pharmacology , Delayed-Action Preparations/chemistry , Delayed-Action Preparations/pharmacology , Dihydrolipoamide Dehydrogenase/chemistry , Dihydrolipoamide Dehydrogenase/pharmacology , Fish Diseases/immunology , Fish Diseases/prevention & control , Nanoparticles/chemistry , Nanoparticles/therapeutic use , Perciformes/immunology , Perciformes/microbiology , Porosity , Silicon Dioxide/chemistry , Silicon Dioxide/pharmacology , Vibrio Infections/immunology , Vibrio Infections/prevention & control , Vibrio Infections/veterinary , Vibrio alginolyticus/enzymology , Vibrio alginolyticus/immunology
3.
Mol Cell Probes ; 56: 101708, 2021 04.
Article in English | MEDLINE | ID: mdl-33636281

ABSTRACT

Mesoporous silica nanoparticles (MSNs) have been used in the field of biomedicine as antigen carriers and adjuvants for protective antigens. In the present study, an oral nanovaccine against Vibrio alginolyticus was prepared employing MSNs as carriers. The uptake of the dihydrolipoamide dehydrogenase (DLDH) antigens in the intestine of large yellow croaker was evaluated using an immunohistochemistry assay. Additionally, the effects of the nanovaccine on the early immune response in large yellow croaker were investigated via oral vaccination. The presence of the antigens was detected in the mucosa and lamina propria of the foregut, midgut, and hindgut of large yellow croaker at 3 h following oral immunization. The expression levels of cytokines (i.e., lysozyme, IFN-γ, IFITM, TNF-α, IL-1ß, IL-2, IL-4, IL-10, and IL-13) in the intestine, spleen, and head kidney tissues of large yellow croaker before and after the immune challenge were determined via RT-qPCR assay. The obtained results revealed that the expression levels of lysozyme, IFN-γ, IFITM, TNF-α, IL-1ß, IL-2, IL-4, IL-10, and IL-13 in the intestine and head kidney of the vaccinated large yellow croaker, as well as the expression of lysozyme, IL-1ß, and IL-10 in the spleen, exhibited time-dependent oscillation regulation patterns. Notably, the nanovaccine immunization could induce early (6 h) and high expression of IFN-γ in the spleen and kidney tissues after the bacterial infection. The current study supplements the available data on the early immune response to fish nanovaccines. It also provides a valuable theoretical basis for the future development of large yellow croaker oral vaccines.


Subject(s)
Antigens, Bacterial/immunology , Bacterial Vaccines/immunology , Dihydrolipoamide Dehydrogenase/immunology , Fish Diseases/prevention & control , Fish Proteins/genetics , Vibrio Infections/veterinary , Vibrio alginolyticus/immunology , Administration, Oral , Animals , Antigens, Bacterial/administration & dosage , Antigens, Bacterial/genetics , Bacterial Vaccines/administration & dosage , Bacterial Vaccines/genetics , Dihydrolipoamide Dehydrogenase/administration & dosage , Dihydrolipoamide Dehydrogenase/genetics , Drug Carriers/administration & dosage , Drug Carriers/chemistry , Fish Diseases/genetics , Fish Diseases/immunology , Fish Diseases/microbiology , Fish Proteins/immunology , Gene Expression , Interferon-gamma/genetics , Interferon-gamma/immunology , Interleukin-10/genetics , Interleukin-10/immunology , Interleukin-13/genetics , Interleukin-13/immunology , Interleukin-1beta/genetics , Interleukin-1beta/immunology , Interleukin-2/genetics , Interleukin-2/immunology , Interleukin-4/genetics , Interleukin-4/immunology , Intestines/drug effects , Intestines/immunology , Intestines/microbiology , Kidney/drug effects , Kidney/immunology , Kidney/microbiology , Muramidase/genetics , Muramidase/immunology , Nanoparticles/administration & dosage , Nanoparticles/chemistry , Perciformes/immunology , Perciformes/microbiology , Silicon Dioxide/chemistry , Silicon Dioxide/immunology , Spleen/drug effects , Spleen/immunology , Spleen/microbiology , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology , Vaccination/methods , Vibrio Infections/immunology , Vibrio Infections/microbiology , Vibrio Infections/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...